Cargando…
Construction of Curcumin and Paclitaxel Co-Loaded Lipid Nano Platform and Evaluation of Its Anti-Hepatoma Activity in vitro and Pharmacokinetics in vivo
PURPOSE: The present study aimed to construct a co-loading platform encapsulating curcumin and paclitaxel at ratios of 2:1–80:1 (w/w) designated “CU-PTX-LNP” and explored the synergistic effects of CU-PTX at different composite proportions on liver cancer cells using the combination index (CI) metho...
Autores principales: | Wei, Yuxun, Wei, Yumeng, Sheng, Lin, Ma, Jingwen, Su, Zhilian, Wen, Jie, Li, Lanmei, Jia, Qiang, Liu, Huiyang, Si, Hui, Xiong, Linjin, Chen, Jinglin, Cheng, Ju, Zuo, Ying, Yang, Hongru, Zhao, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135418/ https://www.ncbi.nlm.nih.gov/pubmed/37122500 http://dx.doi.org/10.2147/IJN.S399289 |
Ejemplares similares
-
Review of Curcumin Physicochemical Targeting Delivery System
por: Li, Lanmei, et al.
Publicado: (2020) -
Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo
por: Zhao, Wenmei, et al.
Publicado: (2022) -
The application of extracellular vesicles in colorectal cancer metastasis and drug resistance: recent advances and trends
por: Xiong, Linjin, et al.
Publicado: (2023) -
Novel Curcumin Derivative-Decorated Ultralong-Circulating Paclitaxel Nanoparticles: A Novel Delivery System with Superior Anticancer Efficacy and Safety
por: Wei, Yumeng, et al.
Publicado: (2022) -
Anti-lung cancer effect of paclitaxel solid lipid nanoparticles delivery system with curcumin as co-loading partner in vitro and in vivo
por: Pi, Chao, et al.
Publicado: (2022)